Your browser doesn't support javascript.
loading
Daratumumab inhibits acute myeloid leukaemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cells.
Mistry, Jayna J; Moore, Jamie A; Kumar, Prakritt; Marlein, Christopher R; Hellmich, Charlotte; Pillinger, Genevra; Jibril, Aisha; Di Palma, Federica; Collins, Angela; Bowles, Kristian M; Rushworth, Stuart A.
Afiliação
  • Mistry JJ; University of East Anglia, Norwich Medical School.
  • Moore JA; University of East Anglia, Norwich Medical School.
  • Kumar P; University of East Anglia, Norwich Medical School.
  • Marlein CR; University of East Anglia, Norwich Medical School.
  • Hellmich C; University of East Anglia, Norwich Medical School.
  • Pillinger G; University of East Anglia, Norwich Medical School.
  • Jibril A; University of East Anglia, Norwich Medical School.
  • Di Palma F; Earlham Institute.
  • Collins A; Department of Haematology, Norfolk and Norwich University Hospitals NHS Trust.
  • Bowles KM; University of East Anglia, Norwich Medical School.
  • Rushworth SA; University of East Anglia, Norwich Medical School.
Haematologica ; 106(2): 589-592, 2021 02 01.
Article em En | MEDLINE | ID: mdl-32193250

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Células-Tronco Mesenquimais Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Células-Tronco Mesenquimais Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article